These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7889496)

  • 1. Q-modification of tRNAs in human brain tumors.
    Aytaç U; Gündüz U
    Cancer Biochem Biophys; 1994 Sep; 14(2):93-8. PubMed ID: 7889496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
    Sasaki T; Lopes MB; Hankins GR; Helm GA
    Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of the glucose transporters in human brain tumors.
    Nishioka T; Oda Y; Seino Y; Yamamoto T; Inagaki N; Yano H; Imura H; Shigemoto R; Kikuchi H
    Cancer Res; 1992 Jul; 52(14):3972-9. PubMed ID: 1617673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of queuosine derivatives by reverse-phase liquid chromatography for the hypomodification study of Q-bearing tRNAs from various mammal liver cells.
    Costa A; Païs de Barros JP; Keith G; Baranowski W; Desgrès J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Mar; 801(2):237-47. PubMed ID: 14751792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and cellular localization of messenger RNA for plasminogen activator inhibitor type 1 in human astrocytomas in vivo.
    Yamamoto M; Sawaya R; Mohanam S; Loskutoff DJ; Bruner JM; Rao VH; Oka K; Tomonaga M; Nicolson GL; Rao JS
    Cancer Res; 1994 Jul; 54(13):3329-32. PubMed ID: 8012944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Queuosine modification of tRNA: its divergent role in cellular machinery.
    Vinayak M; Pathak C
    Biosci Rep; 2009 Nov; 30(2):135-48. PubMed ID: 19925456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma.
    Arrieta O; Garcia E; Guevara P; Garcia-Navarrete R; Ondarza R; Rembao D; Sotelo J
    Cancer; 2002 Jun; 94(12):3210-8. PubMed ID: 12115353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of the queuine content of transfer ribonucleic acids to histopathological grading and survival in human lung cancer.
    Huang BS; Wu RT; Chien KY
    Cancer Res; 1992 Sep; 52(17):4696-700. PubMed ID: 1511436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uridine diphosphate sugar in meningiomas of the brain].
    Popova GM; Promyslov MSh; Gabibov GA
    Zh Vopr Neirokhir Im N N Burdenko; 1996; (3):30-1. PubMed ID: 8975513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific lack of the hypermodified nucleoside, queuosine, in hepatoma mitochondrial aspartate transfer RNA and its possible biological significance.
    Randerath E; Agrawal HP; Randerath K
    Cancer Res; 1984 Mar; 44(3):1167-71. PubMed ID: 6420054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras p21 expression in brain tumors: elevated expression in malignant astrocytomas and glioblastomas multiforme.
    Arvanitis D; Malliri A; Antoniou D; Linardopoulos S; Field JK; Spandidos DA
    In Vivo; 1991; 5(4):317-21. PubMed ID: 1667267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of queuine, a highly modified purine base, in transfer RNAs from primary and metastatic ovarian malignant tumors in women.
    Baranowski W; Dirheimer G; Jakowicki JA; Keith G
    Cancer Res; 1994 Aug; 54(16):4468-71. PubMed ID: 8044797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total acid soluble and insoluble carnitine levels in human brain tumors.
    Sandikci KS; Gümüstaş MK; Tüter Y; Kökoğlu E; Ozyurt E; Sözer V
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):49-57. PubMed ID: 10738901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of lipids from human brain tissues by multinuclear magnetic resonance spectroscopy.
    Tugnoli V; Tosi MR; Tinti A; Trinchero A; Bottura G; Fini G
    Biopolymers; 2001; 62(6):297-306. PubMed ID: 11857268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy.
    Howe FA; Barton SJ; Cudlip SA; Stubbs M; Saunders DE; Murphy M; Wilkins P; Opstad KS; Doyle VL; McLean MA; Bell BA; Griffiths JR
    Magn Reson Med; 2003 Feb; 49(2):223-32. PubMed ID: 12541241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and localization of urokinase-type plasminogen activator receptor in human gliomas.
    Yamamoto M; Sawaya R; Mohanam S; Rao VH; Bruner JM; Nicolson GL; Rao JS
    Cancer Res; 1994 Sep; 54(18):5016-20. PubMed ID: 8069869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and quantification of glycosylated queuosine modified tRNAs by acid denaturing and APB gels.
    Zhang W; Xu R; Matuszek Ż; Cai Z; Pan T
    RNA; 2020 Sep; 26(9):1291-1298. PubMed ID: 32439717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
    Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
    NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of queuosine modification system deficiencies in cultured human cells.
    Morris RC; Galicia MC; Clase KL; Elliott MS
    Mol Genet Metab; 1999 Sep; 68(1):56-67. PubMed ID: 10479483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.